is cagrilintide a glp-1 Semaglutide, glucagon-like peptide-1 (GLP-1) receptor agonist, has well-established weight-loss benefits. Cagrilintide, a long-acting analogue of the satiety hormone amylin, has shown promise for weight loss in early trials. The potential benefit nejm Semaglutide, a glucagon-like peptide-1

The collagen-driven changes that materially alter how skin looks emerge from week 6 to 8 and compound over 3 to 6 months of bi-weekly sessions

DSIP has been investigated in controlled human sleep studies, showing effects on sleep duration, sleep stage distribution, and subjective sleep quality, making it relevant to research on sleep regulation, stress modulation, and recovery

Further animal and in vitro studies suggest that epithalon may inhibit breast adenocarcinoma, linked to its telomerase activity [5]

Published trials show up to 70% increases in collagen output in vitro and significant improvements in skin density in 12-week human clinical studies